MOACM
ADMA icon

Mutual of America Capital Management’s ADMA Biologics ADMA Stock Holding History

Mutual of America Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$245K Buy
27,237
+35
+0.1% +$552 ﹤0.01% 1268
2025
Q4 		$496K Buy
27,202
+471
+2% +$7.94K 0.01% 1070
2025
Q3 		$392K Sell
26,731
-3,937
-13% -$67.5K ﹤0.01% 1121
2025
Q2 		$558K Sell
30,668
-3,755
-11% -$76.6K 0.01% 1064
2025
Q1 		$683K Sell
34,423
-1,384
-4% -$23.9K 0.01% 1054
2024
Q4 		$614K Buy
35,807
+751
+2% +$14.1K 0.01% 1082
2024
Q3 		$701K Buy
+35,056
New +$545K 0.01% 1081

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Mutual of America Capital Management's ADMA Position: Q1 2026 in Review

Mutual of America Capital Management increased its ADMA Biologics (ADMA) stake by 0.13% in Q1 2026, buying an estimated $552 and bringing the position to 27,237 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Mutual of America Capital Management first reported a position in ADMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $701K in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Mutual of America Capital Management held 27,237 shares of ADMA Biologics worth $245K as of Q1 2026.
  • Mutual of America Capital Management bought 35 ADMA Biologics shares in Q1 2026, an estimated $552.
  • ADMA Biologics made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q1 2026, its #1268 holding.
  • Mutual of America Capital Management first reported a position in ADMA Biologics in Q3 2024 and has held it in 7 quarters since.
  • Mutual of America Capital Management's ADMA Biologics position peaked at $701K in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.